Peter M. Jokich

TL;DR: The ACR Appropriateness Criteria as mentioned in this paper are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel and used to recommend imaging and treatment procedures.

TL;DR: The ACR Appropriateness Criteria as discussed by the authors are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel and used to recommend imaging or treatment.

TL;DR: The ACR Appropriateness Criteria(®) are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel and include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology.

TL;DR: The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel and include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology.

TL;DR: Evidence provides little justification for performing imaging to exclude metastasis in asymptomatic women with stage I breast cancer; however, survival rates do not differ between women who obtain intensive screening and surveillance, with imaging and laboratory studies, and women who undergo testing only as a result of development of symptoms or findings on clinical examinations.